Dr. Carlayne Jackson, professor of neurology and otolaryngology, co-authored a new study that includes the results of a small clinical trial for an oral drug that slowed ALS patients’ rate of functional decline.
Newsroom
Dr. Carlayne Jackson, professor of neurology and otolaryngology, co-authored a new study that includes the results of a small clinical trial for an oral drug that slowed ALS patients’ rate of functional decline.